The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Vander Vort John since year 2005.
The trader's CIK number is 1379218.
At the time of this reporting, Vander Vort John is the Director of Aratana Therapeutics, Inc. .
(stock ticker symbol PETX).
See this page for all insider trading activities at Aratana Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-03-06||PETX||Aratana Therapeutics, Inc.||Sale||6,137||20.01||122,776|
|2013-07-30||CNAT||Conatus Pharmaceuticals Inc||Buy||165,265||11.00||1,817,915|
|2013-07-02||PETX||Aratana Therapeutics, Inc.||Buy||500,000||6.00||3,000,000|
|2013-03-11||PCRX||Pacira Pharmaceuticals, Inc.||Sale||500,000||27.86||13,930,000|
|2007-09-14||MEMY||Memory Pharmaceuticals Corp||Sale||27,600||2.10||57,960|
|2007-09-13||MEMY||Memory Pharmaceuticals Corp||Sale||62,180||2.12||132,070|
|2007-09-12||MEMY||Memory Pharmaceuticals Corp||Sale||10,000||2.16||21,610|
|2006-12-18||MEMY||Memory Pharmaceuticals Corp||Buy||2,315,151||1.11||2,569,817|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vander Vort John (Director of Aratana Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.